Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 163.30 |
---|---|
High | 163.30 |
Low | 163.30 |
Bid | 163.80 |
Offer | 165.80 |
Previous close | 161.20 |
Average volume | 797.71 |
---|---|
Shares outstanding | 66.54m |
Free float | 66.17m |
P/E (TTM) | 35.30 |
Market cap | 11.70bn USD |
EPS (TTM) | 4.98 USD |
Annual div (ADY) | 1.66 EUR |
---|---|
Annual div yield (ADY) | 1.03% |
Div ex-date | Oct 24 2024 |
Div pay-date | Nov 14 2024 |
Data delayed at least 15 minutes, as of Nov 11 2024 07:06 GMT.
More ▼
- Aptar Reports Third Quarter 2024 Results
- Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
- Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
- Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
- Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
More ▼